Looks like you were anxiously waiting.... Or maybe it's

New Post Public Reply Private Reply Replies (0) Message Board
Mauibound
387
Looks like you were anxiously waiting....
Or maybe it's that new lazy c that was?

It's almost game time Johnny W Petro
The game is Petro-Si-No
It's the racists bigot favorite game.
Si or No

Johnny W are you ready?

The game is usually FAAFO or TMPB.
But that's for later. Ohh so fun.

There may be answers explained and there may not be.
The reason is two fold, it's to show what an absolute know nothing POS Johnny Racist is and now I know it will irritate the hell out of this new lazy c that begs for attention. They'll respond, they can't help themselves. Haha and I know it. Oh how this eats at you.
To reply or not. Such a sad weak clown,, 100% will respond.

So, don't count on me doing all the DD for you.
That will get of the racists lapdogs all riled up, barking and biting each other. Morons.

Ok, let's ring that bell....

FDA won't approve or go near #Tollovid
Todos Medical Receives New FDA Certificate of Free Sale for Tollovid Daily™ Including 3CL Protease Inhibitor Claim - July 22, 2022
https://investor.todosmedical.com/news-events...e-sale-for

Todos Medical Receives FDA Certificate of Free Sale for New 5-Day Tollovid Dosing Regimen
May 04, 2021
https://investor.todosmedical.com/news-events...le-for-new


Covid is over - well it depends on how flat the earth is in Neptune! NJ, NJ means not joking kinda like JK but the opposite and I darn it, autocorrect changed it, meant to say on Neptune.

3CL will never get done - No, not correct again
Don't have to look far
https://investor.todosmedical.com/news-events/press-releases


RS is happening soon - John W Petro Si No??
No again , you been screaming that for years now!

Filings will never happen, ugh maybe you just never learned how to read. I mean FEMA should have tested you for that.

No one will buy Tollovid -
yawn, again wrong , how many Msold? And still selling and ramping up foe even more sales.

There are no Ph 3 results ***
Well, that 1 you got correct. I mean an idiot babbles long enough they are bound to say saw something so stupid it actually is correct.
Phase 3 hasn't begun yet

Gerald will destroy the company - let's see, No! Getting bigger, worldwide in fact.
How's that POS scam you love so much.
A worldwide crypto scam that can only be used in the US, but hasn't even been created?
Huh? FFS how stupid are you

No one will ever deal with Gerald -
Well, some of the best and brightest minds not only make deals with him, they also work for him now.
Ooooh zing for that special someone

They won't ever get a trial for Tollovir
No, wrong.

Changes the story after the completes trial releases incredible results to
There were only 31 people so it doesn't mean anything...

Well, ask the 100% of those 31 people that we in the hospital if it meant anything to them. They all lived!
As opposed to the 22% of hospitalized patients that took the placebo and pasted away.
Died you POS, do you get that. Oh you do understand, just just don't care.
https://investor.todosmedical.com/news-events...-secondary

You continue to hate Gerald and people are dying. Yet, He and what he brought into Todos is saving lives.
Why don't you or your family member step up?
Lemme guess you'd rather take a hoax.
Maybe just drink bleach.


The Company will get buried under all this covid stuff that's useless anyway
Refer to the previous wrong answer if yours.
3CL Pharma will focus on developing therapeutics, diagnostics and dietary supplements based on 3CL protease (3CLpro, Main Protease, Mpro, Nsp5) https://investor.todosmedical.com/news-events/press-releases/detail/180/todos-medical-completes-acquisition-of-key-assets-and

Is the only thing that matters SEC filings?
And here your answer Petro Si No, well which is it? You and your Scam companies or real filings by real companies with real revenue?
https://investorshub.advfn.com/boards/read_ms...=166217966

Gerald is getting fired - no

Only a seasoned 'silver haired fox' and executive BP leader can actually run companies right
How dumb are you is a better question.
Is Allison your silver haired fox.
"I Love Alison"
Also CEO' take all the blame...again except for your POS scam
https://investorshub.advfn.com/boards/read_ms...=168379737

I'm a cheerleader...hahaha
https://investorshub.advfn.com/boards/read_ms...=168298103


Part A Gerald won't be able to close the Provista Lab deal

And Part B to reinforce how stupid you are.
Provista Labs will be useless until 2025 at best

"We have invested heavily in our newly-acquired Provista Diagnostics lab capabilities and leadership in order to be properly positioned to capture cyclical COVID testing revenue in preparation for the launch of our Videssa breast cancer blood test in early 2023,"
https://investor.todosmedical.com/news-events...uarter-and

And again, No Johnny Racist, actually ramping up for even more workflow generating real revenue.


See how much of a fing POS and moron you are
Johnny Dumbazz.

Ok now the real fun begins.

Listen, it's no secret where you work or the house you live in. You put it alllll out there.

I mean, the DD I personally do for myself on companies I own stake in take far more time than 3 clicks. I mean really John, you put it all out there.
Sorry, baxk to the other game I mentioned.

What day will the envelope show up at your work? With alll those PM's and all those Racist statements.
All in color and timestamped.
See Petro, you never met me. I invited you to come meet me more than a few times. But now at your age, 66 coming up on 67, and with a grand baby on the way (poor kid) wonder if they will speak with you...ugh sidetracked again see you don't know what I am capable of.
I see 100% what you are capable of. And we are not in the same ballpark.

The FAAFO game, F around and find out
TM MF, try me.

My guess is FEMA won't like being associated with AH's like you. And won't be happy about the time stamps in those posts nevermind the content

So keep trying to kill people with your false misleading Racist bigoted statements. Please and one day you will get that call. Maybe I will even call you before and let you know the tracking number.

Some said I live for vengeance and I'll work on myself in hell. No sure who said that, but it is an interesting thought.

As I've watched my daughter grow I too have grown. I've grown impatient with your attacks. Before it was just me, but now you are trying to get people killed of which could be my family and friends and that is now a line too far. Harm my investment? Take food out of my families mouth, I'm not sure if you get the game you thinkbyour playing, but there are some who are not laughing.
Believe.

PM me if you want to FAAFO,.
It will be easy, just say mail it or you can even swear at me. I've never blocked you and you can still reach out here or on Twitter, I know you stalk.

Also if anyone has posts of his that they want included in the packet, just PM me the link, I'll print it .

Also, I hear the SEC doesn't like to Fake financial advisors.

Tiktok Brah

Todos Med Ltd. (TOMDF) Stock Research Links

TOMDF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 178

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 10

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 197

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Runway Growth Acquires SWK Holdings in Major Merger Deal

Updated Category News Views 292

Runway Growth Announces Acquisition of SWK Holdings Runway Growth Finance Corp. (NASDAQ: RWAY) has made a significant move by announcing its acquisition of SWK Holdings Corporation (NASDAQ: SWKH). This strategic deal, valued at around $220 million, reflects Runway's ambition to enhance its investment portfolio. Details of the Acquisition Deal The acquisition will be...

Continue Reading
Generative AI Market for Software and Coding Set for Growth

Updated Category News Views 149

Overview of the Generative AI Market The Generative AI in Software and Coding market is on a promising trajectory, with projections indicating a remarkable increase from USD 31.6 million by 2024 to USD 243.7 million by 2033, a CAGR of 25.5%. This growth reflects the rise of AI technologies capable of automating code generation and software development, streamlining...

Continue Reading
Explore NebulaGraph Cloud: Affordable Beta Access Awaits

Updated Category News Views 77

NebulaGraph Cloud Beta Preview on AWS Global We’re launching the beta preview of NebulaGraph Cloud on AWS Global, and you can try it for up to $1 for a full month. Starting now through the end of November, you can explore a highly scalable, high?performance graph database without a big upfront commitment. Spin it up, kick the tires, and see how it fits your workload....

Continue Reading
Exploring Gold's Surge: Implications for GoldHaven Resources

Updated Category News Views 198

Gold Prices Rise Amid Economic Turmoil Gold prices have experienced a remarkable rise, surging over 25% since the start of the year and stabilizing near the $4,000 per ounce mark. This increase is driven by a wave of investors looking for safe-haven assets amidst persistent inflation and economic uncertainty. Central banks have noticeably been boosting their gold...

Continue Reading
Illinois Tool Works Adjusts Earnings Outlook Amid Observer Changes

Updated Category News Views 237

Illinois Tool Works Inc. Announcements Following Q3 Results Illinois Tool Works Inc. (NYSE: ITW) recently released its third-quarter results for fiscal 2025, showcasing a mix of performance metrics that caught the interest of analysts and investors alike. The company reported a revenue increase of 2.3% year-over-year, amounting to $4.06 billion. However, this result fell...

Continue Reading